StockData

Goldenwell Biotech, Inc. (GWLL) income statement

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
21.8%
Operating margin
-208729.1%
Net margin
-512940.0%
Return on equity, FY2025
151.7%

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
11.1%

Valuation

P/E ratio
–
Price to sales
1170000.00
Price to book
–
Dividend yield
–

See a number that looks wrong?